USE OF COMFA IN VALIDATING THE CONFORMATION USED IN DESIGNING 4-(1H-BENZIMIDAZOLE-2-CARBONYL)PIPERIDINES WITH H-1 NK1 RECEPTOR ANTAGONIST ACTIVITY/

Authors
VAZ RJ MAYNARD GD KUDLACZ EM BRATTON LD KANE JM SHATZER SA KNIPPENBERG RW
Citation
Rj. Vaz et al., USE OF COMFA IN VALIDATING THE CONFORMATION USED IN DESIGNING 4-(1H-BENZIMIDAZOLE-2-CARBONYL)PIPERIDINES WITH H-1 NK1 RECEPTOR ANTAGONIST ACTIVITY/, Bioorganic & medicinal chemistry letters, 7(22), 1997, pp. 2825-2830
Citations number
13
Journal title
Bioorganic & medicinal chemistry letters → ACNP
ISSN journal
0960894X
Volume
7
Issue
22
Year of publication
1997
Pages
2825 - 2830
Database
ISI
SICI code
0960-894X(1997)7:22<2825:UOCIVT>2.0.ZU;2-9
Abstract
Support for the conformation used in the design of a series of 4-(1H-b enzimidazole-2-carbonyl)piperidines with dual histamine H-1/tachykinin NK1 receptor antagonist activity has been presented. Comparative Mole cular Field Analysis(CoMFA) for both receptor binding affinites of the series as well as overlays with several crystal structures of selecti ve receptor antagonists support the conformation. (C) 1997 Elsevier Sc ience Ltd.